Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Clinical Cancer Research

• Publication date

  2000-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 10815926
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines.

  1999cited by this paper
• Enhancement of Tumor Response to γ-Radiation by an Inhibitor of Cyclooxygenase-2 Enzyme

  1999cited by this paper
• Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.

  1999cited by this paper
• Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas.

  1999cited by this paper
• Trends of Lung Cancer Incidence by Histologic Type: A Population‐based Study in Osaka, Japan

  1999cited by this paper
• Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.

  1998cited by this paper
• Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone).

  1998cited by this paper
• NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.

  1998cited by this paper
• Cyclooxygenase-2 inhibitors in tumorigenesis (part I).

  1998cited by this paper
• Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs).

  1998cited by this paper
• Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).

  1998cited by this paper
• Do newer chemotherapeutic agents improve survival in non-small cell lung cancer?

  1998cited by this paper
• Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols.

  1997cited by this paper
• Aspirin use and potential mechanisms for colorectal cancer prevention.

  1997cited by this paper
• In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: An overview

  1997cited by this paper
• Establishment of human peripheral lung epithelial cell lines (HPL1) retaining differentiated characteristics and responsiveness to epidermal growth factor, hepatocyte growth factor, and transforming growth factor beta1.

  1997cited by this paper
• Nimesulide. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

  1994cited by this paper
• Towards a better aspirin

  1994cited by this paper
• Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer.

  1993cited by this paper
• Glutathione S-transferase pi levels in a panel of lung cancer cell lines and its relation to chemo-radiosensitivity.

  1993influential reference
• Human cyclooxygenase-2 cDNA.

  1992cited by this paper
• p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking.

  1992cited by this paper
• Effects of sulindac and oltipraz on the tumorigenicity of 4-(methylnitrosamino)1-(3-pyridyl)-1-butanone in A/J mouse lung.

  1992cited by this paper
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

  1990cited by this paper
• Lack of in vitro synergy between etoposide and cis-diamminedichloroplatinum(II).

  1989cited by this paper
• Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay.

  1989cited by this paper
• Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes.

  1988cited by this paper
• Cancer : Principles and Practice of Oncology

  1982cited by this paper
• Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity.

  1979cited by this paper
• CANCER OF THE LUNG

  1959cited by this paper
• [Cancer of the lung].

  1952cited by this paper

• Two-Level Spatially Localized Proximity Labeling for Cross-Biological-Hierarchy Measurement and Manipulation.

  2025cites this paper
• Fluorinated High‐Valent Sn(IV) Porphyrins Show Remarkable Photodynamic Activity in Cancer Cells

  2024cites this paper
• Celecoxib inhibits NLRP1 inflammasome pathway in MDA-MB-231 Cells

  2024cites this paper
• Metronomic chemotherapy in cancer treatment: new wine in an old bottle

  2024cites this paper
• Technological Advancement in ω-3 fatty acids: its Therapeutic Functions and Novel Delivery Strategies.

  2023cites this paper
• Combinational study with network pharmacology, molecular docking and preliminary experiments on exploring common mechanisms underlying the effects of weijing decoction on various pulmonary diseases

  2023cites this paper
• A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies

  2023cites this paper
• Exploration of efficacy, cellular responses, and safety profile of novel 9-(3-Pyridyl) noscapine derivatives as promising anticancer candidates

  2023cites this paper
• Effects of ruminal LPS exposure on primary bovine ruminal epithelial cells.

  2023cites this paper
• Simultaneous pulmonary administration of celecoxib and naringin using a nebulization-friendly nanoemulsion: A device-targeted delivery for treatment of lung cancer

  2022cites this paper
• Combination Regimen of Amino-Noscapine and Docetaxel for Evaluation of Anticancer Activity

  2021cites this paper
• Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update

  2021cites this paper
• Regulation of inflammation and COX-2 gene expression in benzo (a) pyrene induced lung carcinogenesis in mice by all trans retinoic acid (ATRA).

  2021cites this paper
• Comparison of the benefits of celecoxib combined with anticancer therapy in advanced non-small cell lung cancer: A meta-analysis

  2020cites this paper
• Phytochemical constituents of sterol-rich fraction from Allium cepa L. and its cytotoxic effect on human embryonic kidney (HEK293) cells.

  2020cites this paper
• Crosstalk between ER-stress and apoptosis in irradiated HepG2 cells with gemcitabine: implication of PI3K/AKT and IκB/NF-κB signaling pathways

  2020cites this paper
• Rational design of 9-vinyl-phenyl noscapine as potent tubulin binding anticancer agent and evaluation of the effects of its combination on Docetaxel

  2020cites this paper
• Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.

  2020influential citation
• Mixed-Generation PAMAM G3-G0 Megamer as a Drug Delivery System for Nimesulide: Antitumor Activity of the Conjugate Against Human Squamous Carcinoma and Glioblastoma Cells

  2019cites this paper
• Visible light-induced cytotoxicity studies on Co(ii) complexes having an anthracene-based curcuminoid ligand.

  2019cites this paper
• mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines.

  2019cites this paper
• The Role of Prostaglandin-Endoperoxide Synthase-2 in Chemoresistance of Non-Small Cell Lung Cancer

  2019cites this paper
• Next generation sequencing identifies novel potential actionable mutations for grade I meningioma treatment.

  2019cites this paper
• Nimesulide analogues: From anti-inflammatory to antitumor agents.

  2019cites this paper
• Two Novel tri-aryl Derivatives Attenuate the Invasion- Promoting Effects of Stromal Mesenchymal Stem Cells on Breast Cancer.

  2019cites this paper
• Possible role of PPAR-γ and COX-2 receptor modulators in the treatment of Non-Small Cell lung carcinoma.

  2019cites this paper
• Synthesis and Different Effects of Biotinylated PAMAM G3 Dendrimer Substituted with Nimesulide in Human Normal Fibroblasts and Squamous Carcinoma Cells

  2019cites this paper
• Systematic review and meta-analysis of the benefit of celecoxib in treating advanced non-small-cell lung cancer

  2018cites this paper
• Antineoplastic influence of nimesulide in chemically induced hepatocellular carcinoma by inhibition of DNA synthesis

  2018cites this paper
• Phase II study of celecoxib with docetaxel chemoradiotherapy followed by consolidation chemotherapy docetaxel plus cisplatin with maintenance celecoxib in inoperable stage III nonsmall cell lung cancer

  2018cites this paper
• Surfactant Free Preparation of Celecoxib Microcrystals by a Controlled Precipitation Process

  2017cites this paper
• 7 Lung Tumor Microenvironment and Myelomonocytic Cells

  2017cites this paper
• Nanostructured lipid carriers

  2017cites this paper
• Anti-tumour efficacy of etoposide alone and in combination with piroxicam against canine osteosarcoma in a xenograft model.

  2017cites this paper
• Structural Probing, Screening and Structure-Based Drug Repositioning Insights into the Identification of Potential Cox-2 Inhibitors from Selective Coxibs

  2017cites this paper
• PLEIOTROPIC EFFECTS OF CALCIUM D-GLUCARATE ON CHEMICALLY- INDUCED LUNG CARCINOGENESIS IN A/J MICE

  2017cites this paper
• The association between regular use of aspirin and the prevalence of prostate cancer

  2016influential citation
• Grape Seed Procyanidin Extract Mediates Antineoplastic Effects against Lung Cancer via Modulations of Prostacyclin and 15-HETE Eicosanoid Pathways

  2016cites this paper
• Does celecoxib improve the efficacy of chemotherapy for advanced non-small cell lung cancer?

  2016cites this paper
• Long-term results of a phase I/II trial of the addition of celecoxib to chemoradiotherapy for locally advanced or recurrent squamous cell carcinoma of the head-and-neck

  2016cites this paper
• Celecoxib suppresses autophagy and enhances cytotoxicity of imatinib in imatinib-resistant chronic myeloid leukemia cells

  2016cites this paper
• Novel combination of Vincristine and COX-2 Inhibitor Nimesulide provides synergistic antiproliferative and pro-apoptotic effects in KOSC-2 oral squamous carcinoma cells

  2016cites this paper
• Effects of etoposide alone and in combination with piroxicam on canine osteosarcoma cell lines.

  2016cites this paper
• Celecoxib Treatment Alters p53 and MDM2 Expression via COX-2 Crosstalk in A549 Cells

  2016cites this paper
• Relationship between epidermal growth factor receptor (EGFR) mutation and serum cyclooxygenase-2 Level, and the synergistic effect of celecoxib and gefitinib on EGFR expression in non-small cell lung cancer cells.

  2015cites this paper
• Formulation and optimization of celecoxib-loaded PLGA nanoparticles by the Taguchi design and their in vitro cytotoxicity for lung cancer therapy

  2015cites this paper
• Gallic acid induces mitotic catastrophe and inhibits centrosomal clustering in HeLa cells.

  2015influential citation
• Atom-based QSAR and 3D QSAR using pharmacophore based alignment for discovery of nimesulide-derived SKBR-3 cell line inhibitors

  2015cites this paper
• Potency of non-steroidal anti-inflammatory drugs in chemotherapy (Review)

  2015cites this paper
• Cyclooxygenase 2 inhibition in patients with non–small cell lung cancer: Is this still a valid target for therapy?

  2015cites this paper
• The interplay between GRP78 expression and Akt activation in human colon cancer cells under celecoxib treatment

  2015cites this paper
• Clinical overview of metronomic chemotherapy in breast cancer

  2015cites this paper
• Potency of non-steroidal anti-inflammatory drugs in chemotherapy.

  2015cites this paper
• Flaxseed reduces the pro-carcinogenic micro-environment in the ovaries of normal hens by altering the PG and oestrogen pathways in a dose-dependent manner.

  2015cites this paper
• Development of Resistance to Targeted Therapy: Preclinical Findings and Clinical Relevance

  2015cites this paper
• Hypoxia promotes 786-O cells invasiveness and resistance to sorafenib via HIF-2α/COX-2

  2014cites this paper
• COX-2 overexpression and -8473 T/C polymorphism in 3′ UTR in non-small cell lung cancer

  2014cites this paper
• Mitochondria: The Anti- cancer Target for the Third Millennium

  2014cites this paper
• Exploiting Celecoxib in Cancer Therapy

  2014cites this paper
• Interleukin-10 Superfamily and Cancer

  2014cites this paper
• The immunoinhibitory B7-H1 molecule as a potential target in cancer: killing many birds with one stone.

  2014cites this paper
• Molecular Landscape of Induced Reprogramming: A Dissertation

  2014cites this paper
• Molecular Biology of Lung Preneoplasia

  2014cites this paper
• Meloxicam synergistically enhances the in vitro effects of sunitinib malate on bladder-cancer cells

  2013influential citation
• Prognostic value of COX-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.

  2013cites this paper
• Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

  2013cites this paper
• Efficacy of Aerosolized Celecoxib Encapsulated Nanostructured Lipid Carrier in Non-small Cell Lung Cancer in Combination with Docetaxel

  2013cites this paper
• Indomethacin-Enhanced Anticancer Effect of Arsenic Trioxide in A549 Cell Line: Involvement of Apoptosis and Phospho-ERK and p38 MAPK Pathways

  2013cites this paper
• Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer

  2013cites this paper
• Honokiol Inhibits Non-Small Cell Lung Cancer Cell Migration by Targeting PGE2-Mediated Activation of β-Catenin Signaling

  2013cites this paper
• Targeting apoptosis pathways by Celecoxib in cancer.

  2013cites this paper
• Estudio de la resistencia a quimioterapia en células con características de cancer stem cells (CSC) derivadas de cáncer no microcítico de pulmón (CNMP)

  2013cites this paper
• cancer for dose-dependent effect Evaluation of cyclooxygenase-2 inhibition in an orthotopic murine model of lung

  2013cites this paper
• Supercritical fluid technology based large porous celecoxib-PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose.

  2013cites this paper
• Silicate fiber-based 3D cell culture system for anticancer drug screening.

  2013cites this paper
• Lentivirus-mediated shRNA interference targeting cyclooxygenase-2 inhibits growth of human non-small cell lung cancer.

  2013cites this paper
• Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts

  2013cites this paper
• Stem Cell‐Based Antiangiogenic Therapies for Brain Tumors

  2013cites this paper
• Lung cancer chemoprevention: current status and future directions

  2012cites this paper
• Myeloid suppressor cells and immune modulation in lung cancer.

  2012cites this paper
• Nanostructured lipid carriers (NLCs) for drug delivery and targeting.

  2012cites this paper
• Effects of silencing cyclooxygenase-2 expression via RNA interference on the tumorigenicity of the SMMC-7721 human hepatocarcinoma cell line.

  2012cites this paper
• Staying a Step Ahead of Cancer

  2012cites this paper
• Antitumor properties of taxol in combination with cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian tumor growth in vivo.

  2012cites this paper
• Lung Tumor Microenvironment and Myelomonocytic Cells

  2012cites this paper
• Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo

  2012cites this paper
• Cyclooxygenase-2 expression is not a marker of poor survival in lung cancer.

  2012cites this paper
• Insufficient Radiofrequency Ablation Promotes Angiogenesis of Residual Hepatocellular Carcinoma via HIF-1α/VEGFA

  2012cites this paper
• From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation.

  2012cites this paper
• Critical aspects in rationale design of fluorouracil-based adjuvant therapies for the management of colon cancer.

  2012cites this paper
• Cyclooxygenase-2 expression is not associated with clinical outcome in synovial sarcoma.

  2011cites this paper
• Lung Cancer Chemoprevention with Celecoxib in Former Smokers

  2011cites this paper
• Translational Research in Cancer Drug Development

  2011influential citation
• Cyclooxygenase-2 Confers Growth Advantage to Syngeneic Pancreatic Cancer Cells

  2011cites this paper
• Functional genetic variations of cyclooxygenase‐2 and susceptibility to acute myeloid leukemia in a Chinese population

  2011cites this paper
• Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients

  2011cites this paper
• Preoperative Taxane-Based Chemotherapy and Celecoxib for Carcinoma of the Esophagus and Gastroesophageal Junction: Results of a Phase 2 Trial

  2011cites this paper
• Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma

  2011cites this paper
• Clinical Aspects of Inflammation in Non-small Cell Lung Cancer

  2011cites this paper
• In vitro and in vivo effects of a cyclooxygenase-2 inhibitor nimesulide analog JCC76 in aromatase inhibitors-insensitive breast cancer cells.

  2011cites this paper